Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Sartor
Observed names:
C Sartor,
C. Sartor,
SARTOR, CHIARA,
Sartor, C,
Sartor, Chiara
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna,
University of Bologna
ORCID:
0000-0002-2356-5691
Observed ORCID:
0000-0002-2356-5691
OpenAlex ID:
A5019480794
DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours
2010
·
Marco Novelli
, Sabrina Rossi
, et al.
·
Histopathology
·
216
Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size
2010
·
Sabrina Rossi
, Daniela Gasparotto
, et al.
·
The American Journal of Surgical Pathology
·
140
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia
2021
·
Giovanni Martinelli
, Cristina Papayannidis
, et al.
·
Blood Advances
·
81
PDF
Multiple Primary Sporadic Gastrointestinal Stromal Tumors in the Adult: An Underestimated Entity
2008
·
Daniela Gasparotto
, Sabrina Rossi
, et al.
·
Clinical Cancer Research
·
78
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2017
·
Giovanni Martinelli
, Alfonso Piciocchi
, et al.
·
Blood
·
72
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
2018
·
Andrea Ghelli Luserna Di Rorà
, Neil Beeharry
, et al.
·
Journal of Hematology & Oncology
·
58
PDF
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
2016
·
Andrea Ghelli Luserna Di Rorà
, Ilaria Iacobucci
, et al.
·
Oncotarget
·
42
PDF
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
2021
·
Simone Ragaini
, Sarah Wagner
, et al.
·
Blood Advances
·
33
PDF
A venetoclax and azacitidine bridge‐to‐transplant strategy for NPM1‐ mutated acute myeloid leukaemia in molecular failure
2023
·
C. Sartor
, L. Brunetti
, et al.
·
British Journal of Haematology
·
32
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin
2022
·
Sabine Kayser
, Chiara Sartor
, et al.
·
Haematologica
·
29
PDF
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
2019
·
Andrea Ghelli Luserna Di Rorà
, Matteo Bocconcelli
, et al.
·
Cancers
·
29
PDF
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax
2023
·
Anna Candoni
, Davide Lazzarotto
, et al.
·
American Journal of Hematology
·
28
PDF
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients
2015
·
Elisa Zuffa
, Eugenia Franchini
, et al.
·
Oncotarget
·
28
PDF
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia
2024
·
Dorian Forte
, Roberto Maria Pellegrino
, et al.
·
Nature Communications
·
27
PDF
Acute Myeloid Leukemia Mutations: Therapeutic Implications
2019
·
Cristina Papayannidis
, Chiara Sartor
, et al.
·
International Journal of Molecular Sciences
·
27
PDF
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
2023
·
Sabine Kayser
, Chiara Sartor
, et al.
·
Haematologica
·
25
PDF
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
2018
·
Luca Bertamini
, Jacopo Nanni
, et al.
·
BMC Cancer
·
22
PDF
Rationale for a Pediatric-Inspired Approach in the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia, with a Focus on Asparaginase Treatment
2014
·
Carmelo Rizzari
, Maria Caterina Putti
, et al.
·
Hematology Reports
·
19
PDF
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study
2023
·
Nicola Stefano Fracchiolla
, Mariarita Sciumè
, et al.
·
Cancers
·
18
PDF
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
2022
·
Sarah Parisi
, Loredana Ruggeri
, et al.
·
Frontiers in Immunology
·
15
PDF
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant
2021
·
Cristina Papayannidis
, Chiara Sartor
, et al.
·
Hematological Oncology
·
15
Revised “iRR6” model in intermediate‐1 risk myelofibrosis patients treated with ruxolitinib
2025
·
Francesca Palandri
, Filippo Branzanti
, et al.
·
Cancer
·
14
PDF
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review
2024
·
Flavia Bigi
, Enrica Manzato
, et al.
·
Pharmaceuticals
·
14
PDF
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission
2024
·
Anna Candoni
, Patrizia Chiusolo
, et al.
·
Cancers
·
14
PDF
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
2022
·
Ilaria Vigliotta
, Silvia Armuzzi
, et al.
·
Frontiers in Oncology
·
14
PDF
Show more works
View as search
Works count:
193
Citation count:
1,336
H-index:
18
I10-index:
32
Year
Topic
Type